Healthcare provider profile · identity verified

Sandhya Sureddi, MD

Internal Medicine · SOUTH MILWAUKEE, WI · NPI 1124134655

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	161
Levothyroxine Sodium	Levothyroxine Sodium	429	102
Amlodipine Besylate	Amlodipine Besylate	412	112
Omeprazole	Omeprazole	412	109
Metoprolol Succinate	Metoprolol Succinate	409	98
Losartan Potassium	Losartan Potassium	373	100
Pantoprazole Sodium	Pantoprazole Sodium	313	83
Simvastatin	Simvastatin	287	74
Lisinopril	Lisinopril	286	72
Rosuvastatin Calcium	Rosuvastatin Calcium	279	72
Furosemide	Furosemide	269	62
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	176	46
Tramadol Hcl	Tramadol Hcl	158	28
Potassium Chloride	Potassium Chloride	157	30
Metoprolol Tartrate	Metoprolol Tartrate	150	40
Albuterol Sulfate Hfa	Albuterol Sulfate	142	42
Escitalopram Oxalate	Escitalopram Oxalate	132	35
Hydrochlorothiazide	Hydrochlorothiazide	131	38
Metformin Hcl	Metformin Hcl	127	37
Pravastatin Sodium	Pravastatin Sodium	120	31
Meloxicam	Meloxicam	111	32
Allopurinol	Allopurinol	108	28
Metformin Hcl Er	Metformin Hcl	108	34
Gabapentin	Gabapentin	106	34
Eliquis	Apixaban	103	22
Tizanidine Hcl	Tizanidine Hcl	101	30
Trazodone Hcl	Trazodone Hcl	101	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	26
Glimepiride	Glimepiride	92	29
Fluticasone Propionate	Fluticasone Propionate	91	31
Clopidogrel	Clopidogrel Bisulfate	90	30
Famotidine	Famotidine	88	28
Zolpidem Tartrate	Zolpidem Tartrate	73	15
Alendronate Sodium	Alendronate Sodium	66	19
Citalopram Hbr	Citalopram Hydrobromide	65	19
Nystatin	Nystatin	62	18
Paroxetine Hcl	Paroxetine Hcl	59	15
Warfarin Sodium	Warfarin Sodium	58	15
Hydroxyzine Hcl	Hydroxyzine Hcl	56	23
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	55	12
Clonidine Hcl	Clonidine Hcl	52	11
Bupropion Xl	Bupropion Hcl	51	16
Sertraline Hcl	Sertraline Hcl	51	12
Pregabalin	Pregabalin	48	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	46	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	37
Amoxicillin	Amoxicillin	44	25
Lorazepam	Lorazepam	44	suppressed
Montelukast Sodium	Montelukast Sodium	44	13
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Carvedilol	Carvedilol	40	suppressed
Lovastatin	Lovastatin	40	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	40	15
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	13
Memantine Hcl	Memantine Hcl	38	suppressed
Alprazolam	Alprazolam	35	14
Celecoxib	Celecoxib	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Myrbetriq	Mirabegron	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Meclizine Hcl	Meclizine Hcl	33	17
Topiramate	Topiramate	33	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Cephalexin	Cephalexin	30	23
Diclofenac Sodium	Diclofenac Sodium	30	14
Ozempic	Semaglutide	30	suppressed
Atenolol	Atenolol	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	13
Enalapril Maleate	Enalapril Maleate	25	suppressed
Azithromycin	Azithromycin	23	21
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Fluconazole	Fluconazole	21	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Cefdinir	Cefdinir	19	18
Chlorthalidone	Chlorthalidone	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Diazepam	Diazepam	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Prednisone	Prednisone	12	12
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Estradiol	Estradiol	11	suppressed
Finasteride	Finasteride	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error